Ausgabe 11/2013
Inhalt (7 Artikel)
Breath Tests to Phenotype Drug Disposition in Oncology
Frans L. Opdam, Anil S. Modak, Hans Gelderblom, Henk-Jan Guchelaar
Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs
Philip N. Patsalos
Pharmacokinetics and Pharmacodynamics of Anticoagulants in Paediatric Patients
Donald L. Yee, Sarah H. O’Brien, Guy Young
Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir
Mackenzie L. Cottrell, Tanja Hadzic, Angela D. M. Kashuba
Pharmacokinetics of Oral Recombinant Human Parathyroid Hormone [rhPTH(1–31)NH2] in Postmenopausal Women with Osteoporosis
Amy Sturmer, Nozer Mehta, Jenna Giacchi, Tulin Cagatay, Roxanne Tavakkol, Sheela Mitta, Lorraine Fitzpatrick, Jeff Wald, John Trang, William Stern
Population Pharmacokinetics of JNJ-37822681, a Selective Fast-Dissociating Dopamine D2-Receptor Antagonist, in Healthy Subjects and Subjects with Schizophrenia and Dose Selection Based on Simulated D2-Receptor Occupancy
Eef Hoeben, Martine Neyens, Erik Mannaert, Mark Schmidt, An Vermeulen
Population Pharmacokinetics of Sifalimumab, an Investigational Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus
Rajesh Narwal, Lorin K. Roskos, Gabriel J. Robbie